TGFB1 and neoplasm: Using non-cytotoxic/non-cytostatic doses of IFN-β, we saw a significant repression of OSM- and TGF-β-induced stemness (reduced tumor sphere formation, migratory capacity, and a lack of CD44 induction) (Figs. 1 and 2).